Doctors test dropping a drug to make cancer transplants safer
NCT ID NCT05256537
Summary
This study is testing whether a standard stem cell transplant for blood cancers can be done safely without one of the immune-suppressing drugs (mycophenolate mofetil or MMF). The goal is to see if removing this drug reduces side effects while still controlling the cancer. The trial will follow 60 adult patients for up to two years after their transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Conditions
Explore the condition pages connected to this study.